587 related articles for article (PubMed ID: 33099572)
21. Mettl3 inhibits the apoptosis and autophagy of chondrocytes in inflammation through mediating Bcl2 stability via Ythdf1-mediated m
He Y; Wang W; Xu X; Yang B; Yu X; Wu Y; Wang J
Bone; 2022 Jan; 154():116182. PubMed ID: 34530171
[TBL] [Abstract][Full Text] [Related]
22. METTL3-induced DLGAP1-AS2 promotes non-small cell lung cancer tumorigenesis through m
Zhang Q; Zhang Y; Chen H; Sun LN; Zhang B; Yue DS; Wang CL; Zhang ZF
Cell Cycle; 2022 Dec; 21(24):2602-2614. PubMed ID: 35972892
[TBL] [Abstract][Full Text] [Related]
23. METTL3/YTHDF2 m6A axis accelerates colorectal carcinogenesis through epigenetically suppressing YPEL5.
Zhou D; Tang W; Xu Y; Xu Y; Xu B; Fu S; Wang Y; Chen F; Chen Y; Han Y; Wang G
Mol Oncol; 2021 Aug; 15(8):2172-2184. PubMed ID: 33411363
[TBL] [Abstract][Full Text] [Related]
24. N6-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization.
Chen C; Yuan W; Zhou Q; Shao B; Guo Y; Wang W; Yang S; Guo Y; Zhao L; Dang Q; Yang X; Wang G; Kang Q; Ji Z; Liu J; Sun Z
Theranostics; 2021; 11(9):4298-4315. PubMed ID: 33754062
[TBL] [Abstract][Full Text] [Related]
25. YTHDF1-enhanced iron metabolism depends on TFRC m
Ye J; Wang Z; Chen X; Jiang X; Dong Z; Hu S; Li W; Liu Y; Liao B; Han W; Shen J; Xiao M
Theranostics; 2020; 10(26):12072-12089. PubMed ID: 33204330
[No Abstract] [Full Text] [Related]
26. METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N
Wan W; Ao X; Chen Q; Yu Y; Ao L; Xing W; Guo W; Wu X; Pu C; Hu X; Li Z; Yao M; Luo D; Xu X
Mol Cancer; 2022 Feb; 21(1):60. PubMed ID: 35197058
[TBL] [Abstract][Full Text] [Related]
27. N
Li Z; Peng Y; Li J; Chen Z; Chen F; Tu J; Lin S; Wang H
Nat Commun; 2020 May; 11(1):2578. PubMed ID: 32444598
[TBL] [Abstract][Full Text] [Related]
28. METTL3/YTHDF2 m
Xie H; Li J; Ying Y; Yan H; Jin K; Ma X; He L; Xu X; Liu B; Wang X; Zheng X; Xie L
J Cell Mol Med; 2020 Apr; 24(7):4092-4104. PubMed ID: 32126149
[TBL] [Abstract][Full Text] [Related]
29. METTL3-mediated m
Liu HT; Zhao Y; Wang HC; Liu QL
Biochem Biophys Res Commun; 2024 Jul; 716():150039. PubMed ID: 38701556
[TBL] [Abstract][Full Text] [Related]
30. N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.
Wang H; Xu B; Shi J
Gene; 2020 Jan; 722():144076. PubMed ID: 31454538
[TBL] [Abstract][Full Text] [Related]
31. METTL3 mediated m
Zhou R; Gao Y; Lv D; Wang C; Wang D; Li Q
Biochem Biophys Res Commun; 2019 Jul; 515(2):310-317. PubMed ID: 31153635
[TBL] [Abstract][Full Text] [Related]
32. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.
Dou X; Wang Z; Lu W; Miao L; Zhao Y
BMC Pulm Med; 2022 Aug; 22(1):324. PubMed ID: 36008805
[TBL] [Abstract][Full Text] [Related]
33. METTL3 regulates the malignancy of cervical cancer via post-transcriptional regulation of RAB2B.
Hu Y; Li Y; Huang Y; Jin Z; Wang C; Wang H; Xu J
Eur J Pharmacol; 2020 Jul; 879():173134. PubMed ID: 32339511
[TBL] [Abstract][Full Text] [Related]
34. METTL3 Modulates Osteoclast Differentiation and Function by Controlling RNA Stability and Nuclear Export.
Li D; Cai L; Meng R; Feng Z; Xu Q
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121289
[TBL] [Abstract][Full Text] [Related]
35. m
Wang L; Hui H; Agrawal K; Kang Y; Li N; Tang R; Yuan J; Rana TM
EMBO J; 2020 Oct; 39(20):e104514. PubMed ID: 32964498
[TBL] [Abstract][Full Text] [Related]
36. HOXC13 promotes cervical cancer proliferation, invasion and Warburg effect through β-catenin/c-Myc signaling pathway.
Dai M; Song J; Wang L; Zhou K; Shu L
J Bioenerg Biomembr; 2021 Oct; 53(5):597-608. PubMed ID: 34309767
[TBL] [Abstract][Full Text] [Related]
37. METTL3-mediated m
Wang Q; Chen C; Ding Q; Zhao Y; Wang Z; Chen J; Jiang Z; Zhang Y; Xu G; Zhang J; Zhou J; Sun B; Zou X; Wang S
Gut; 2020 Jul; 69(7):1193-1205. PubMed ID: 31582403
[TBL] [Abstract][Full Text] [Related]
38. METTL3 promotes proliferation and myogenic differentiation through m
Zhao T; Zhao R; Yi X; Cai R; Pang W
Life Sci; 2022 Jun; 298():120496. PubMed ID: 35351467
[TBL] [Abstract][Full Text] [Related]
39. METTL3 potentiates resistance to cisplatin through m
Wei J; Yin Y; Zhou J; Chen H; Peng J; Yang J; Tang Y
J Cell Mol Med; 2020 Oct; 24(19):11366-11380. PubMed ID: 32857912
[TBL] [Abstract][Full Text] [Related]
40. METTL3-m
Peng Z; Gong Y; Wang X; He W; Wu L; Zhang L; Xiong L; Huang Y; Su L; Shi P; Cao X; Liu R; Li Y; Xiao H
Mol Ther; 2022 Feb; 30(2):932-946. PubMed ID: 34547464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
